PYXS peer analysis
Pyxis Oncology (PYXS) against its competitors: price, today's move, 1-year return and market value side by side.
- PYXS's peers: AVIR (Atea Pharmaceuticals), CRBU (Caribou Biosciences), ENTA (Enanta Pharmaceuticals), FHTX (Foghorn Therapeutics), HUMA (Humacyte), IMRX (Immuneering), TNYA (Tenaya Therapeutics), VYGR (Voyager Therapeutics).
PYXS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AVIR Atea Pharmaceuticals | $3.97 | 1.02% | 26.03% | $318.81M |
| CRBU Caribou Biosciences | $0.30 | -4.86% | -83.77% | $31.91M |
| ENTA Enanta Pharmaceuticals | $7.62 | -4.51% | -37.18% | $222.19M |
| FHTX Foghorn Therapeutics | $1.66 | -6.74% | -65.84% | $99.54M |
| HUMA Humacyte | $0.46 | -14.97% | -60.57% | $128.15M |
| IMRX Immuneering | $3.33 | -3.48% | -53.56% | $215.66M |
| TNYA Tenaya Therapeutics | $0.29 | -1.54% | -75.30% | $66.99M |
| VYGR Voyager Therapeutics | $1.53 | -4.97% | -63.22% | $95.21M |
| ZURA Zura Bio | $0.93 | -2.34% | -75.97% | $89.59M |
| PYXS Pyxis Oncology | $1.81 | 7.74% | -60.39% | $216.49M |